Literature DB >> 33419113

Theoretical Analysis of the Built-in Metabolic Pathway Effect on the Metabolism of Erythrocyte-Bioreactors That Neutralize Ammonium.

Evgeniy Protasov1,2, Larisa Koleva1,2, Elizaveta Bovt1,2, Fazoil I Ataullakhanov1,2,3,4, Elena Sinauridze1,2.   

Abstract

The limitations of the efficiency of ammonium-neutralizing erythrocyte-bioreactors based on glutamate dehydrogenase and alanine aminotransferase reactions were analyzed using a mathematical model. At low pyruvate concentrations in the external medium (below about 0.3 mM), the main limiting factor is the rate of pyruvate influx into the erythrocyte from the outside, and at higher concentrations, it is the disappearance of a steady state in glycolysis if the rate of ammonium processing is higher than the critical value (about 12 mM/h). This rate corresponds to different values of glutamate dehydrogenase activity at different concentrations of pyruvate in plasma. Oxidation of reduced nicotinamide adenine dinucleotide phosphate (NADPH) by glutamate dehydrogenase decreases the fraction of NADPH in the constant pool of nicotinamide adenine dinucleotide phosphates (NADP + NADPH). This, in turn, activates the pentose phosphate pathway, where NADP reduces to NADPH. Due to the increase in flux through the pentose phosphate pathway, stabilization of the ATP concentration becomes impossible; its value increases until almost the entire pool of adenylates transforms into the ATP form. As the pool of adenylates is constant, the ADP concentration decreases dramatically. This slows the pyruvate kinase reaction, leading to the disappearance of the steady state in glycolysis.

Entities:  

Keywords:  ammonium removal; erythrocyte; erythrocyte-bioreactor; limitations of the erythrocyte-bioreactor efficiency; mathematical modeling

Year:  2021        PMID: 33419113      PMCID: PMC7825432          DOI: 10.3390/metabo11010036

Source DB:  PubMed          Journal:  Metabolites        ISSN: 2218-1989


  24 in total

1.  A new chemotherapeutic agent: L-asparaginase entrapped in red blood cells.

Authors:  E I Sinauridze; V M Vitvitsky; A V Pichugin; A M Zhabotinsky; F I Ataullakhanov
Journal:  Adv Exp Med Biol       Date:  1992       Impact factor: 2.622

2.  Recombinant human alpha-glucosidase from rabbit milk in Pompe patients.

Authors:  H Van den Hout; A J Reuser; A G Vulto; M C Loonen; A Cromme-Dijkhuis; A T Van der Ploeg
Journal:  Lancet       Date:  2000-07-29       Impact factor: 79.321

3.  Deficiencies of glycolytic enzymes as a possible cause of hemolytic anemia.

Authors:  M V Martinov; A G Plotnikov; V M Vitvitsky; F I Ataullakhanov
Journal:  Biochim Biophys Acta       Date:  2000-03-06

Review 4.  Hyperammonemia in review: pathophysiology, diagnosis, and treatment.

Authors:  Ari Auron; Patrick D Brophy
Journal:  Pediatr Nephrol       Date:  2011-03-23       Impact factor: 3.714

5.  Encapsulation of glutamine synthetase in mouse erythrocytes: a new procedure for ammonia detoxification.

Authors:  Elena A Kosenko; Natalia I Venediktova; Andrey A Kudryavtsev; Fazoil I Ataullakhanov; Yury G Kaminsky; Vicente Felipo; Carmina Montoliu
Journal:  Biochem Cell Biol       Date:  2008-12       Impact factor: 3.626

6.  The influence of enzyme concentration on the encapsulation of glutamate dehydrogenase and alcohol dehydrogenase in red blood cells.

Authors:  S Sanz; M Pinilla; M Garín; K F Tipton; J Luque
Journal:  Biotechnol Appl Biochem       Date:  1995-10       Impact factor: 2.431

7.  [Interaction of the Embden-Meyerhof pathway and hexose monophosphate shunt in erythrocytes].

Authors:  F I Ataullakhanov; V N Buravtsev; A M Zhabotinskiĩ; S B Norina; A V Pichugin
Journal:  Biokhimiia       Date:  1981-04

8.  Amino acid transport in human and in sheep erythrocytes.

Authors:  J D Young; S E Jones; J C Ellory
Journal:  Proc R Soc Lond B Biol Sci       Date:  1980-09-26

9.  Erythrocytes as bioreactors to decrease excess ammonium concentration in blood.

Authors:  Eugeniy S Protasov; Daria V Borsakova; Yuliya G Alexandrovich; Anatoliy V Korotkov; Elena A Kosenko; Andrey A Butylin; Fazoil I Ataullakhanov; Elena I Sinauridze
Journal:  Sci Rep       Date:  2019-02-06       Impact factor: 4.379

Review 10.  Imiglucerase in the treatment of Gaucher disease: a history and perspective.

Authors:  Patrick B Deegan; Timothy M Cox
Journal:  Drug Des Devel Ther       Date:  2012-04-18       Impact factor: 4.162

View more
  1 in total

1.  Ammonium removal by erythrocyte-bioreactors based on glutamate dehydrogenase from Proteus sp. jointly with porcine heart alanine aminotransferase.

Authors:  Daria V Borsakova; Larisa D Koleva; Evgeniy S Protasov; Fazoil I Ataullakhanov; Elena I Sinauridze
Journal:  Sci Rep       Date:  2022-03-31       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.